Jane Street’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Jane Street’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,335	Closed	-$146K	–	6131
2019 Q2	$146K	Buy	+10,335	New	+$98.3K	﹤0.01%	4771
2018 Q2	–	Sell	-8,120	Closed	-$220K	–	5938
2018 Q1	$220K	Buy	+8,120	New	+$243K	﹤0.01%	4370

Other funds holding DOVA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's DOVA Position: Q3 2019 in Review

Jane Street sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2019, closing a stake of 10,335 shares — an estimated $146K sold.

Jane Street first reported a position in DOVA in Q1 2018 and held it in 2 quarters. The position peaked at $220K in Q1 2018. 72 funds tracked by Wall St. Rank hold DOVA as of Q3 2019.

Jane Street reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Jane Street sold 10,335 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $146K.
Jane Street first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 2 quarters.
Jane Street's Dova Pharmaceuticals, Inc. Common Stock position peaked at $220K in Q1 2018.
72 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Jane Street's 13F filing for Q3 2019, filed 14 Nov 2019.